Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2005-2105PMID 16551733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

  2005cited by this paper
• Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

  2005cited by this paper
• Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes.

  2005cited by this paper
• Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.

  2005cited by this paper
• Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.

  2005cited by this paper
• Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.

  2005cited by this paper
• Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo*

  2005cited by this paper
• Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature

  2004cited by this paper
• FGF23 is processed by proprotein convertases but not by PHEX.

  2004cited by this paper
• Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.

  2004cited by this paper
• Tumor-induced rickets: usefulness of MR gradient echo recall imaging for tumor localization.

  2004cited by this paper
• Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna.

  2004influential reference
• FGF-23 in patients with end-stage renal disease on hemodialysis.

  2004cited by this paper
• Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

  2004cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003cited by this paper
• FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

  2003cited by this paper
• FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

  2003cited by this paper
• Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003influential reference
• Fibroblast Growth Factor 23: A New Clinical Marker for Oncogenic Osteomalacia

  2003cited by this paper
• Hypophosphatemia, osteomalacia and proximal muscle weakness treated by surgery.

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

  2002cited by this paper
• Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism

  2002cited by this paper
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002cited by this paper
• The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

  2001cited by this paper
• Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Oncogenic osteomalacia: is there a new phosphate regulating hormone?

  1997cited by this paper
• NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATION

  1975cited by this paper

• A nomogram for predicting surgery outcome of tumor-induced osteomalacia: a case-control study

  2025cites this paper
• PET/CT and Paraneoplastic Syndromes: A Comprehensive Review

  2025cites this paper
• Tumour-induced osteomalacia.

  2025cites this paper
• Failure of femoral internal fixation device secondary to phosphaturic mesenchymal tumor: a case report and literature review

  2025cites this paper
• Model‐Informed Approach to Recommend Burosumab Dosing Regimens for Pediatric and Adult Patients With the Ultrarare Disease Tumor‐Induced Osteomalacia

  2024cites this paper
• A retrospective cohort of tumor-induced osteomalacia and case series of malignant disease.

  2024cites this paper
• The Intricacies of Renal Phosphate Reabsorption—An Overview

  2024cites this paper
• Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review

  2024cites this paper
• Fibroblast growth factor 23 in children with or without heart failure: a prospective study

  2023cites this paper
• Tumor-induced osteomalacia: An overview.

  2023cites this paper
• Co-occurrence of Spondyloepiphyseal Dysplasia and X-Linked Hypophosphatemia in a Three-Generation Chinese Family

  2023cites this paper
• UPLC-MS based serum metabolomics for early diagnosis of refractory tumor-induced osteomalacia: a case-control study.

  2023cites this paper
• Burosumab Improves Patient‐Reported Outcomes in Adults With Tumor‐Induced Osteomalacia: Mixed‐Methods Analysis

  2023cites this paper
• [Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children].

  2023cites this paper
• Intact Fibroblast Growth Factor 23 (iFGF23) Concentrations in Hypophosphatemic Disorders.

  2023cites this paper
• Associations between endogenous sex hormones and FGF-23 among women and men in the Multi-Ethnic Study of Atherosclerosis

  2022cites this paper
• Phosphatonins: From Discovery to Therapeutics.

  2022cites this paper
• Determination of FGF23 Levels for the Diagnosis of FGF23‐Mediated Hypophosphatemia

  2022cites this paper
• The effect of burosumab on intact and C‐terminal FGF23 measurements

  2022cites this paper
• Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis

  2022cites this paper
• Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

  2022cites this paper
• The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations

  2022cites this paper
• Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

  2022cites this paper
• TUMOR-INDUCED OSTEOMALACIA: A COMPREHENSIVE REVIEW.

  2022cites this paper
• Phosphatonins

  2021cites this paper
• FGF23: A Review of Its Role in Mineral Metabolism and Renal and Cardiovascular Disease

  2021cites this paper
• Clinical performance of a novel chemiluminescent enzyme immunoassay for FGF23

  2021cites this paper
• Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis

  2021cites this paper
• Comparison of 18F‐FDG PET/CT and 68Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia

  2021cites this paper
• Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system

  2021cites this paper
• Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23

  2020cites this paper
• Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron‐Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets

  2020cites this paper
• Diagnosis of TIO: Is Serum FGF23 Measurement always the Answer?

  2020cites this paper
• A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia

  2020influential citation
• Race, Ancestry and Vitamin D Metabolism: The Multi-Ethnic Study of Atherosclerosis.

  2020cites this paper
• A rare cause of atraumatic fractures: case series of four patients with tumor-induced osteomalacia

  2020cites this paper
• The genetic polymorphisms of XPR1 and SCL34A3 are associated with Fanconi syndrome in Chinese patients of tumor-induced osteomalacia

  2020cites this paper
• Fibroblast Growth Factor 23 and Long-Term Cardiac Function

  2020cites this paper
• Burosumab for the Treatment of Tumor‐Induced Osteomalacia

  2020cites this paper
• Selective pharmacological inhibition of the sodium-dependent phosphate co-transporter NPT2a promotes phosphate excretion.

  2020cites this paper
• Nonremission and Recurrent Tumor‐Induced Osteomalacia: A Retrospective Study

  2019cites this paper
• Fibroblast growth factor 23 and phosphate homeostasis.

  2019cites this paper
• Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur

  2019cites this paper
• FGF23 at the crossroads of phosphate, iron economy and erythropoiesis

  2019cites this paper
• Tumor-induced osteomalacia: experience from three tertiary care centers in India

  2019cites this paper
• Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.

  2019cites this paper
• Tumor-induced osteomalacia with the culprit lesion located in the palm: a case report

  2019cites this paper
• FGF23, Hypophosphatemia, and Emerging Treatments

  2019cites this paper
• FGF23: Clinical usefulness and analytical evolution.

  2019cites this paper
• Successful Localization Using 68Ga-DOTATOC PET/CT of a Phosphaturic Mesenchymal Tumor Causing Osteomalacia in a Patient with Concurrent Follicular Lymphoma

  2018cites this paper
• Phosphaturic mesenchymal tumors: what an endocrinologist should know

  2018cites this paper
• Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy

  2018cites this paper
• Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA

  2018cites this paper
• Tumor-induced osteomalacia

  2018cites this paper
• Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study

  2018influential citation
• Associations Between Intravenous Iron, Inflammation and FGF23 in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5

  2018cites this paper
• Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients

  2018cites this paper
• Coexisting B- Cell Lymphoma and Benign Mesenchymal Phospaturic Tumor: Debut as Acute Renal Failure Associated with Hypercalcemia and Hypophosphatemia

  2018cites this paper
• Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm

  2018cites this paper
• Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO)

  2018cites this paper
• Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children

  2017cites this paper
• Tumor-induced Osteomalacia: A Sherlock Holmes Approach to Diagnosis and Management

  2017cites this paper
• Sex and Iron Modify Fibroblast Growth Factor 23 (FGF23) Concentration in 1-Year-Old Children

  2017cites this paper
• TUMOR-INDUCED OSTEOMALACIA DUE TO HITHERTO UNDIAGNOSED SUBCUTANEOUS PHOSPHATURIC MESENCHYMAL TUMOR

  2017cites this paper
• Tumour-induced osteomalacia

  2017cites this paper
• Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management

  2017cites this paper
• Evaluation of a New Fully Automated Assay for Plasma Intact FGF23

  2017cites this paper
• Oncogenic Osteomalacia Secondary to a Metastatic Phosphaturic Mesenchymal Tumor in the Talus: A Case Report and Review of the Literature

  2017cites this paper
• Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function

  2017cites this paper
• Interorgan handling of fibroblast growth factor-23 in humans.

  2017cites this paper
• Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.

  2017cites this paper
• Tumor-induced osteomalacia: experience from a South American academic center

  2017cites this paper
• Response of Npt2a knockout mice to dietary calcium and phosphorus

  2017cites this paper
• Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease

  2016cites this paper
• Assessment of the relationship between serum soluble Klotho and carotid intima–media thickness and left ventricular dysfunction in hemodialysis patients

  2016cites this paper
• Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury

  2016cites this paper
• The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children.

  2016cites this paper
• Fibroblast Growth Factor 23 Concentrations Reflect Sex Differences in Mineral Metabolism and Growth in Early Infancy

  2016cites this paper
• Austin Journal of Cardiovascular Disease and Atherosclerosis Can Fibroblast Growth Factor-23 Improve Prognostication in Heart Failure Patients?

  2016cites this paper
• Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging.

  2016cites this paper
• Vitamin D deficiency and supplementation : Studies from infancy to young adulthood

  2016cites this paper
• Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study.

  2016cites this paper
• Phosphaturic mesenchymal tumor of the brain without tumor-induced osteomalacia in an 8-year-old girl: case report.

  2016cites this paper
• AN ovelPHEX Mutation in Japanese Patients with X-Linked Hypophosphatemic Rickets

  2015cites this paper
• 68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia

  2015cites this paper
• A Novel PHEX Mutation in Japanese Patients with X-Linked Hypophosphatemic Rickets

  2015cites this paper
• Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic Osteomalacia

  2015cites this paper
• Fibroblast Growth Factor 23, but not Parathyroid Hormone, Is Associated With Urinary Phosphate Regulation in Patients on Peritoneal Dialysis

  2015cites this paper
• A Practical Clinical Approach to Paediatric Phosphate Disorders.

  2015cites this paper
• Development of A Cell-Based Assay to Identify Small Molecule Inhibitors of FGF23 Signaling

  2015cites this paper
• Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.

  2015cites this paper
• Fibroblast Growth Factor 23

  2015cites this paper
• Soluble α-Klotho Serum Levels in Chronic Kidney Disease

  2015cites this paper
• Coupling FGF 23 Production and Cleavage : Iron Deficiency , Rickets and Kidney Disease

  2015cites this paper
• Physiology of the developing kidney: Disorders and therapy of calcium and phosphorous homeostasis

  2015cites this paper
• Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease

  2014cites this paper
• Tumor-induced osteomalacia—a diagnostic dilemma for an orthopedic surgeon

  2014cites this paper
• Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population: The Multi-Ethnic Study of Atherosclerosis

  2014cites this paper
• Relationship Between Residual Renal Function and Serum Fibroblast Growth Factor 23 in Patients on Peritoneal Dialysis

  2014cites this paper
• Utilidad clínica de la determinación del factor de crecimiento de los fibroblastos 23 en la valoración de pacientes con osteomalacia

  2014cites this paper